HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressional Appropriators Press FDA For Feminine Cleanser Guidance

This article was originally published in The Rose Sheet

Executive Summary

Colorants approved exclusively for external use are central to concerns raised about feminine wash products by NGO Women’s Voices for the Earth and its ears in Congress. However, FDA’s ongoing review could explore the broader question of whether such items are properly classified and controlled.

You may also be interested in...



US House Bill Would Define ‘Natural’ Cosmetic, Provide FDA Enforcement Authority

Beautycounter is among industry supporters of the Natural Cosmetic Act, introduced in the House on 5 October as the solution to greenwashing in the US personal-care sector.

FDA Denies WVE Petition For Feminine Wash Colorant Guidance

FDA doesn’t see a need for the guidance requested by Women’s Voices for the Earth, but that doesn’t mean the NGO’s point was entirely lost on the agency. Feminine washes continue to contain colorants permitted for external use only – a seeming paradox, particularly in light of pH balance claims.

Feminine Cleanser Marketing Never Without Challenges; Now The Category Has FDA’s Attention

FDA is investigating use of certain ingredients in feminine cleansing and hygiene products, according to its fiscal 2019 budget justification. The agency’s work could draw unfavorable attention to a category that already comes under fire regularly for alleged body shaming and disproportionate ill effects on women of color, among other accusations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel